Home / Business / Business News / Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

December 01, 2023 Business, Business News

Other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of AbbVie's buyout of ImmunoGen.

from Business News https://ift.tt/LBqK4eo
via IFTTT https://ift.tt/aycUuVx

No comments

Subscribe to: Post Comments ( Atom )